Atossa Therapeutics Inc (NASDAQ:ATOS)
| 0.7535 Delayed Data As of Dec 01 |  +0.0104 / +1.40%Today’s Change | 0.50 Today|||52-Week Range 1.39 | +42.57% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -15.8M | -6.4M | -8.1M | -11.4M | |
| Depreciation | 272.6K | 303.5K | 129.0K | 44.2K | ||
| Total Other Cash Flow | 1.2M | 1.8M | 1.7M | 2.5M | ||
| Funds From Operations | -14.3M | -4.3M | -6.3M | -8.9M | ||
| Funds From/For Other Operating Expenses | -601.1K | 1.3M | 339.9K | 64.4K | ||
| Net Cash Flow - Operating Activities | -13.7M | -5.6M | -6.6M | -9.0M | ||
| Investing | Capital Expenditures | -130.7K | -9.2K | 0.00 | -110.9K | |
| Other Investing - Uses | -157.7K | 0.00 | 0.00 | 0.00 | ||
| Net Cash Flow Investing | -288.4K | -9.2K | 0.00 | -110.9K | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | 9.5M | 4.7M | 10.8M | 12.3M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | -- | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | -- | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 9.5M | 4.7M | 10.8M | 12.3M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -4.5M | -907.9K | 4.2M | 3.2M | ||
